Barclays Maintains Overweight on Equifax, Lowers Price Target to $225
Barclays analyst Manav Patnaik maintains Equifax (NYSE:EFX) with a Overweight and lowers the price target from $230 to $225.
UnitedHealth To Rally 24%? Here Are 5 Other Price Target Changes For Thursday
Raymond James raised the price target on UnitedHealth Group Incorporated (NYSE: UNH) from $620 to $635. Raymond James analyst John Ransom maintained the stock with a Strong Buy rating. UnitedHealth shares rose 0.1% to $512.50 in pre-market trading.
Atlantic Equities Maintains Neutral on Equifax, Lowers Price Target to $200
Atlantic Equities analyst Simon Clinch maintains Equifax (NYSE:EFX) with a Neutral and lowers the price target from $225 to $200.
‘Furthering Access To Credit With Equifax And Zest AI’
https://www.equifax.com/newsroom/all-news/-/story/furthering-access-to-credit-with-equifax-and-zest-ai/
ZEST AI, a leader in expanding access to credit through enhanced scoring, recently announced its partnership with
Equifax’s Return On Capital Employed Insights
Pulled from Benzinga Pro data, Equifax (NYSE:EFX) posted Q2 earnings of $201.40 million, an increase from Q1 of 9.61%. Sales dropped to $1.32 billion, a 3.37% decrease between quarters.
Equifax: Dividend Insights
Thursday marks the last chance for investors to receive the next dividend payout from Equifax (NYSE:EFX).
Analyst Ratings for Equifax
Equifax (NYSE:EFX) has observed the following analyst ratings within the last quarter:
Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
Equifax May Face Class-action Suit after Credit-score Glitch
-Bloomberg
https://www.bloomberg.com/news/articles/2022-08-04/equifax-faces-class-action-lawsuit-after-credit-score-glitch